First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers☆
Review articleOpen access
2013/10/09 Full-length article DOI: 10.1016/j.vaccine.2013.08.007
Highlights•Report on first-in-human safety and immunogenicity testing of a genetically attenuated parasite (GAP) P. falciparum strain.•Five out of six volunteers remained peripheral blood smear negative after GAP-infected mosquitoe bite.•Severe attenuation and favorable immune responses following administration p52−/p36− GAP were observed.•Results suggest that further development of live-attenuated GAP strains using genetic engineering should be pursued.
Request full text